Standard Engineering Technology gains on inking pact with API Pharma Pharmaceutical Trading L.L.C
Standard Engineering Technology is currently trading at Rs. 120.00, up by 1.50 points or 1.27% from its previous closing of Rs. 118.50 on the BSE.
The scrip opened at Rs. 133.00 and has touched a high and low of Rs. 133.00 and Rs. 119.40 respectively. So far 12426 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 203.40 on 17-Sep-2025 and a 52 week low of Rs. 110.70 on 02-Feb-2026.
Last one week high and low of the scrip stood at Rs. 133.50 and Rs. 116.55 respectively. The current market cap of the company is Rs. 2383.93 crore.
The promoters holding in the company stood at 60.47%, while Institutions and Non-Institutions held 3.29% and 36.24% respectively.
Standard Engineering Technology has entered into a Target-Based Conditional Distribution Agreement with API Pharma Pharmaceutical Trading L.L.C, for the Middle East Region as part of its export expansion strategy. The agreement provides for an initial 3 years performance period with defined annual and cumulative business targets. Subject to achievement of these milestones, the arrangement shall continue for a total tenure of upto 10 years.
This arrangement is intended to strengthen the company’s export presence in the Middle East region across: Pharmaceutical manufacturing facilities, Biopharmaceutical and life sciences, Food & Beverages and other process industries. The Middle East region continues to witness sustained investments in pharmaceutical self-sufficiency, biopharma capacity creation, food security programs and diversified industrial infrastructure under long-term economic transformation initiatives. The agreement enables the company to participate in such export-driven growth opportunities through a performance-linked and risk-calibrated model.
